← Eichor
Study identifier: NCT07424963 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Hepatic Venous Pressure Gradient Versus Endoscopic Ultrasound-Guided Portal Pressure Gradient - Comparative Analysis (HEPCA)

Condition: Cirrhosis · Portal Hypertension · EUS  ·  Sponsor: Military University Hospital, Prague

PhaseNA
Planned participants40
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

The goal of this interventional trial is to compare in measuring of portal hypertension by HVPG and EUS-PPG in subject indicated to HVPG measurement. The primary question is whether EUS-PPG provides measurements really equivalent to HVPG in terms of gradient accuracy. Participants undergoing HVPG will first undergo the procedure while conscious, performed by the first operator. Immediately thereafter, HVPG will be repeated following the induction of anesthesia by a second operator blinded to the initial readings. Subsequently, EUS-PPG will be performed by an endoscopist, who will also be blinded to all previous pressure measurements.

This description comes directly from the study's public registry record.

Talk to the study team

Petr Hříbek, MD, PhD  ·  +420973203065  ·  petr.hribek@uvn.cz

Petr Urbánek, Prof.  ·  petr.urbanek@uvn.cz

Always discuss trial participation with your own doctor first.

Locations (2)

Military University Hospital PraguePrague, Bohemia, CzechiaRecruiting
IKEMPrague, CzechiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07424963